- Our Story
- Our Methods
- Quality Improvement
- Health Systems Strengthening
- Social and Behavior Change
- Research and Evaluation
- Education
- Global Health Security
- HIV and AIDS
- Malaria and Zika
- Maternal, Newborn, and Child Health
- Noncommunicable Diseases
- Nutrition
- Reproductive Health and Family Planning
- Tuberculosis
- Vulnerable Children and Families
- Water, Sanitation, and Hygiene
- Our Projects
- Our Resources
- Join Our Team
Improving the Quality of Generic Drugs
File Type: PDF | File Size: 438.39 KB
This white paper reviews the present state, current challenges, and recommended best practices for improving the quality of prescription pharmaceuticals, with an emphasis on generic pharmaceuticals. This white paper covers the following topics:
- Quality Management Systems
- Quality Control
- Public health impact
- Regulatory guidelines
- Auditing/Inspections
This white paper addresses key policy issues, best practices, and key challenges around the pharmaceutical value chain that has an impact on quality of pharmaceuticals available to patients. This white paper also discusses the key stakeholders involved in the quality of medicines (i.e. regulatory bodies, policymakers, and drug manufacturers) and recommendations for future actions.
Resource Type
Publications
Methodology Reports
Regions/ Countries
Language
English